Adding to the checkpoint blockade armamentarium

Nat Med. 2019 Feb;25(2):203-205. doi: 10.1038/s41591-019-0350-5.

Authors

Matthew D Hellmann^{1

2}, Alexandra Snyder³

Affiliations

¹ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Weill Cornell Medical College, New York, NY, USA.
³ Merck, Rahway, NJ, USA. alex.snyder@merck.com.

PMID: 30728540
DOI: 10.1038/s41591-019-0350-5

No abstract available

MeSH terms

Clinical Trials as Topic
Humans
Immunotherapy*
Models, Biological
NK Cell Lectin-Like Receptor Subfamily C / metabolism
Programmed Cell Death 1 Receptor / metabolism
T-Lymphocytes / immunology

Substances

NK Cell Lectin-Like Receptor Subfamily C
Programmed Cell Death 1 Receptor